Studies on agents with mixed NO-dependent and calcium channel antagonistic vasodilating activities

Pharmaceutical Research

Volumn 18, Issue 2, 2001, Pages 157-165

  Cena, Clara ^a   Visentin, Sonja ^a   Di Stilo, Antonella ^a   Boschi, Donatella ^b   Fruttero, Roberta ^a   Gasco, Alberto ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

1,4 dihydropyridines; Ca2+ channel blockers; Furoxans; Hybrid drugs; NO donors; Vasodilation

Indexed keywords

1,4 DIHYDROPYRIDINE; CALCIUM; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; FURAZAN DERIVATIVE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRITE; VASODILATOR AGENT;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHANNEL GATING; CONCENTRATION RESPONSE; DRUG ACTIVITY; DRUG DETERMINATION; DRUG SYNTHESIS; PRIORITY JOURNAL; REACTION ANALYSIS; RECEPTOR BINDING; VASODILATATION;

ANIMALS; AORTA; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR AGENTS; DIHYDROPYRIDINES; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NITRIC OXIDE; NITRIC OXIDE DONORS; RATS; RATS, WISTAR; VASODILATION; VASODILATOR AGENTS;

EID: 0034949015     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011072116210     Document Type: Article

References (16)

1. Drug design
2. Cardiovascular hybrid drugs: Combination of more than one pharmacological property in one single molecule
3. 1antagonist and NO-like vasodilator activities
4. Studies on agents with mixed NO-dependent vasodilating and β-blocking activities
5. New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities
6. 2-antagonists containing NO-donor moieties endowed with mixed antisecretory and gastroselective activities
7. Structure-activity study of antihypertensive 1,4-dihydropyridine derivatives having nitrooxyalkyl moieties at the 3 and 5 positions
8. Synthesis and smooth muscle calcium channel antagonist effects of dialkyl 1,4-dihydro-2,6-dimethyl-4-aryl-3,5-pyridinedicarboxylates containing a nitrooxy or nitrophenyl moiety in the 3-alkyl ester substituent
9. Cardiovascular actions of the furoxan CAS 1609, a novel nitric oxide donor
10. Characterization of furoxans as a new class of tolerance-resistant nitrovasodilators
11. Unsymmetrically substituted furoxans. Part 15. Bromination of dimethylfuroxan related compounds with NBS
12. Unsymmetrically substituted furoxans. Part 16. Reaction of benzenesulfonyl substituted furoxans with ethanol and ethanethiol in basic medium
13. Water soluble furoxan derivatives as NO prodrugs
14. Furoxans as nitric oxide donors. 4-Phenyl-3-furoxancarbonitrile: Thiol-mediated NO release and biological evaluation
15. The pharmacological activity of nitroxyl: A potent vasodilator with activity similar to nitric oxide and/or endothelium-derived factor